Back to Research Hub
Rhythm Pharmaceuticals, Inc.
RYTM
$87.86+1.94 (+2.25%)
Rhythm Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the treatment of rare genetic diseases of obesity.
StreetsValue research for Rhythm Pharmaceuticals, Inc. (RYTM)
Members get the full report for Rhythm Pharmaceuticals, Inc.: a fair value estimate and valuation analysis, economic moat rating, growth and profitability factor grades, a bull and bear investment thesis, analyst price targets, insider and congressional trading activity, and which super investors own the stock.